Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2007
10/02/2007CA2262421C Substituted pyrrolopyrimidines and processes for their preparation
10/02/2007CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
10/02/2007CA2096407C Retroviral protease inhibitors
10/02/2007CA2027341C Process for the preparation of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
09/2007
09/27/2007WO2007108559A1 Agonistic antibody directed against human thrombopoietin receptor
09/27/2007WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein
09/27/2007WO2007108554A1 Peptide having anti-hypertensive activity
09/27/2007WO2007108438A1 External composition for promoting of glutathione production and relevant method
09/27/2007WO2007108434A1 Expression construct for digesting aggregating protein and method of inhibiting the aggregation of aggregating protein
09/27/2007WO2007108272A1 Kit for cancer therapy and pharmaceutical composition for cancer therapy
09/27/2007WO2007108071A1 Antistress composition and food and drink containing the same
09/27/2007WO2007108042A1 Antiinflammatory agent
09/27/2007WO2007107184A1 Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites
09/27/2007US20070225359 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225321 2,4-pyrimidinediamine compounds and their uses
09/27/2007US20070225308 2-Amino Quinazoline Derivative
09/27/2007US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/27/2007US20070225296 Arylalkylamine Compound and Process for Preparing the Same
09/27/2007US20070225287 Substituted Arylpyrazines
09/27/2007US20070225237 Methods for the prevention and/or the treatment of glutamate cytotoxicity
09/27/2007US20070225236 Methods for the prevention and/or the treatment of glutamate cytotoxicity
09/27/2007US20070225235 Methods for the prevention and/or the treatment of glutamate cytotoxicity
09/27/2007US20070225218 Extracellular Messengers
09/27/2007US20070224204 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
09/27/2007US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure
09/27/2007US20070224119 Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer
09/27/2007DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts
09/27/2007DE202007008849U1 Korkmaterial mit Rohdiamant-Partikeln Cork with rough diamond particles
09/27/2007CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein
09/27/2007CA2646460A1 Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites
09/27/2007CA2644663A1 Agonist antibody to human thrombopoietin receptor
09/26/2007EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
09/26/2007EP1837329A1 Novel heteroaryl derivative
09/26/2007EP1837034A1 Remedy for alzheimer´s disease
09/26/2007EP1837033A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR
09/26/2007EP1837032A2 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions
09/26/2007EP1837031A1 Compositions and methods for treating diabetes
09/26/2007EP1837025A2 Method of treating cancer using kinase inhibitors
09/26/2007EP1835907A1 Medicaments for the treatment or prevention of fibrotic diseases
09/26/2007EP1835898A2 Methods for modulating tumor growth and metastasis
09/26/2007EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form
09/26/2007EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
09/26/2007EP1418908B1 Compounds for eliminating and/or relieving anhedonia
09/26/2007EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
09/26/2007EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c
09/26/2007EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
09/26/2007EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/26/2007EP1383750B1 Urea derivatives as integrin alpha 4 antagonists
09/26/2007EP1363650B1 Composition containing pimenta extract in aquatic animal treatment methods
09/26/2007EP1358181B1 Substituted pyrrolidines as ccr-3 receptor antagonists
09/26/2007EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis
09/26/2007EP1313481B1 Pharmaceutical composition comprising condensed indole compound
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/26/2007EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
09/26/2007EP1261585B1 Substituted indole mannich bases
09/26/2007EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
09/26/2007EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors
09/26/2007EP1222255B1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase
09/26/2007EP0937140B1 Antibody molecules which interact specifically with the active site or cleft of a target molecule
09/26/2007CN101043896A Carbohydrase inhibitors derived from fagaceous plants and use thereof
09/26/2007CN101043895A Once a day formulation for phosphate binders
09/26/2007CN101041669A Non nucleoside reverse transcriptase inhibitors
09/26/2007CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
09/26/2007CN101041079A Novel colloid synthetic vectors for gene therapy
09/26/2007CN101041042A Radix curcumae cream Zhongxue plaster for treating spontaneous sweat and night sweat
09/26/2007CN101041025A Pawpaw ferns sweet wine
09/26/2007CN101040998A Mint and reed root beverage for reducing fever
09/26/2007CN101040976A Qinghuo Huadu beverage
09/26/2007CN101040914A Chinese traditional medicine compound for treating insafficiencg of kidney-yang and hypogastric blood stasis
09/26/2007CN101040879A Method for controlling the quality of pine pollen fingerprinting in the resistance-strengthening and stasis-dispersing plant medicine
09/26/2007CN101040875A Physiology injection liquid of deep seawater
09/26/2007CN100339376C Nitrogen-containing aromatic ring derivatives
09/26/2007CN100339374C Compounds and methods for modulation of estrogen receptors
09/26/2007CN100339118C Summer heat clearing toxin resolving granules and its preparation method
09/26/2007CN100339098C Application of coptic toxin resolving decoction in preparation of medicine for predventing and treating tumour chemotherapy tolerance
09/26/2007CN100339088C Medicine for treating child hernia and its preparation method
09/26/2007CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them
09/26/2007CN100339078C Solid drug for oral use
09/26/2007CN100339073C Aryl sulfonamides as serotonin antagonist for treatment of obesity
09/26/2007CN100339023C Embryonic egg health-care food, and its making method
09/25/2007US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses
09/25/2007US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
09/25/2007US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator
09/25/2007US7273873 Camptothecins with a modified lactone ring
09/25/2007US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages
09/25/2007US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007US7273858 Salts
09/25/2007US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes
09/25/2007US7273856 Antagonist of tachykinins like neurokinins and drugs
09/25/2007US7273854 Recombinant adenovirus, adeno-associated virus or herpes virus (especially a replication defective virus) containing a nucleic acid of a specific sequence encoding an antisense RNA that inhibits expression of p53.
09/25/2007US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
09/25/2007US7273846 Selective melanin-concentrating hormone type-1 receptor agonists
09/25/2007US7273744 Heparanase-like polypeptides
09/25/2007US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof
09/25/2007US7273611 Proteinase K resistant surface protein of neisseria meningitidis
09/25/2007US7273602 Immunotherapy for humans
09/25/2007CA2547947C Azole derivatives as active superoxide radical inhibitors
09/25/2007CA2387502C Multiwell scanner and scanning method
09/25/2007CA2376847C Complex of eletriptan and a cyclodextrin derivative